Alex Turner

Alex Turner is the Executive Director of External R&D for Rare Disease at Amgen, a position held since 2023. With an impressive educational background that includes a Ph.D. in Microbiology and Immunology from Stanford University and an A.B. in Biochemical Sciences from Harvard University, Alex has demonstrated exceptional agility in both scientific discovery and drug development. Prior experience includes roles such as Licensing Director at Amgen, Senior Director of Strategic Analysis at Lexicon Pharmaceuticals, and various leadership positions at Horizon and Lexicon Genetics. Alex's career is marked by a strong track record in project management, business development, and contributions to numerous pharmaceutical R&D projects, resulting in 60 issued US patents and over 200 filed applications.